Brent van der Heyden
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Brent van der Heyden has a total of 116 co-authors. Here are the top co-authors by number of shared publications:
- Frank Verhaegen
Maastricht University Medical Centre
14 shared publications - Ana Vaniqui
Belgian Nuclear Research Center (SCK CEN), Mol, Belgium
8 shared publications - Isabel P. Almeida
Department of Radiation Oncology (MAASTRO), GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre , Maastricht , The Netherlands
8 shared publications - Lotte Ejr Schyns
Department of Radiation Oncology (MAASTRO), GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands
5 shared publications Frank Verhaegen
Department of Radiation Oncology (MAASTRO), GROW—School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands
3 shared publicationsWouter van Elmpt
Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands
3 shared publications
Latest Publications
- 3 August 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (15) , 155011
Monte Carlo-based prediction models for nanodroplet-mediated proton range verification
Objective. Radiation-sensitive nanodroplets were recently proposed for in vivo proton range verification. Specifically, the ultrasound contrast generated by radiation-induced droplet vaporization enables visualization of radiation deposition. Here, we developed and validated an in silico model to predict the nanodroplet radiation response from the original treatment plan, ultimately enabling contrast-mediated treatment verification. Approach. By combining the theory of radiation-induced nucleation of superheated emulsions with Monte Carlo simulations, we determined the effective fluence of ionizing particles contributing to the nanodroplet vaporization response. This fluence we assumed to be linearly proportional to the number of vaporization events. The resulting model performance was compared to experimental observations in phantoms and healthy rats . Main results. The modeled effective fluence closely mimicked the vaporization distributions in phantoms, with a sub-millimeter range retrieval performance at body temperature. We also demonstrated the possibility to apply the model directly to preclinical computed tomography scans, yielding promising qualitative agreement with the radiation-induced contrast. Significance. The presented prediction model forms an essential step towards clinical implementation of nanodroplet-mediated proton range verification. Moreover, the simplicity and generalizability of the model enables its use for a wide range of radiotherapy applications.
- 3 August 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (15) , 155011
Monte Carlo-based prediction models for nanodroplet-mediated proton range verification
Objective. Radiation-sensitive nanodroplets were recently proposed for in vivo proton range verification. Specifically, the ultrasound contrast generated by radiation-induced droplet vaporization enables visualization of radiation deposition. Here, we developed and validated an in silico model to predict the nanodroplet radiation response from the original treatment plan, ultimately enabling contrast-mediated treatment verification. Approach. By combining the theory of radiation-induced nucleation of superheated emulsions with Monte Carlo simulations, we determined the effective fluence of ionizing particles contributing to the nanodroplet vaporization response. This fluence we assumed to be linearly proportional to the number of vaporization events. The resulting model performance was compared to experimental observations in phantoms and healthy rats . Main results. The modeled effective fluence closely mimicked the vaporization distributions in phantoms, with a sub-millimeter range retrieval performance at body temperature. We also demonstrated the possibility to apply the model directly to preclinical computed tomography scans, yielding promising qualitative agreement with the radiation-induced contrast. Significance. The presented prediction model forms an essential step towards clinical implementation of nanodroplet-mediated proton range verification. Moreover, the simplicity and generalizability of the model enables its use for a wide range of radiotherapy applications.
- 1 April 2023
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 324 (4) , L400-L412
11β-HSD1 determines the extent of muscle atrophy in a model of acute exacerbation of COPD
Muscle atrophy is an extrapulmonary complication of acute exacerbations (AE) in chronic obstructive pulmonary disease (COPD). The endogenous production and therapeutic application of glucocorticoids (GCs) have been implicated as drivers of muscle loss in AE-COPD. The enzyme 11 β-hydroxysteroid dehydrogenase 1 (11β-HSD1) activates GCs and contributes toward GC-induced muscle wasting. To explore the potential of 11βHSD1 inhibition to prevent muscle wasting here, the objective of this study was to ascertain the contribution of endogenous GC activation and amplification by 11βHSD1 in skeletal muscle wasting during AE-COPD. Emphysema was induced by intratracheal (IT) instillation of elastase to model COPD in WT and 11βHSD1/KO mice, followed by vehicle or IT-LPS administration to mimic AE. µCT scans were obtained prior and at study endpoint 48 h following IT-LPS, to assess emphysema development and muscle mass changes, respectively. Plasma cytokine and GC profiles were determined by ELISA. In vitro, myonuclear accretion and cellular response to plasma and GCs were determined in C2C12 and human primary myotubes. Muscle wasting was exacerbated in LPS-11βHSD1/KO animals compared with WT controls. RT-qPCR and western blot analysis showed elevated catabolic and suppressed anabolic pathways in muscle of LPS-11βHSD1/KO animals relative to WTs. Plasma corticosterone levels were higher in LPS-11βHSD1/KO animals, whereas C2C12 myotubes treated with LPS-11βHSD1/KO plasma or exogenous GCs displayed reduced myonuclear accretion relative to WT counterparts. This study reveals that 11β-HSD1 inhibition aggravates muscle wasting in a model of AE-COPD, suggesting that therapeutic inhibition of 11β-HSD1 may not be appropriate to prevent muscle wasting in this setting.
- 1 April 2023
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 324 (4) , L400-L412
11β-HSD1 determines the extent of muscle atrophy in a model of acute exacerbation of COPD
Muscle atrophy is an extrapulmonary complication of acute exacerbations (AE) in chronic obstructive pulmonary disease (COPD). The endogenous production and therapeutic application of glucocorticoids (GCs) have been implicated as drivers of muscle loss in AE-COPD. The enzyme 11 β-hydroxysteroid dehydrogenase 1 (11β-HSD1) activates GCs and contributes toward GC-induced muscle wasting. To explore the potential of 11βHSD1 inhibition to prevent muscle wasting here, the objective of this study was to ascertain the contribution of endogenous GC activation and amplification by 11βHSD1 in skeletal muscle wasting during AE-COPD. Emphysema was induced by intratracheal (IT) instillation of elastase to model COPD in WT and 11βHSD1/KO mice, followed by vehicle or IT-LPS administration to mimic AE. µCT scans were obtained prior and at study endpoint 48 h following IT-LPS, to assess emphysema development and muscle mass changes, respectively. Plasma cytokine and GC profiles were determined by ELISA. In vitro, myonuclear accretion and cellular response to plasma and GCs were determined in C2C12 and human primary myotubes. Muscle wasting was exacerbated in LPS-11βHSD1/KO animals compared with WT controls. RT-qPCR and western blot analysis showed elevated catabolic and suppressed anabolic pathways in muscle of LPS-11βHSD1/KO animals relative to WTs. Plasma corticosterone levels were higher in LPS-11βHSD1/KO animals, whereas C2C12 myotubes treated with LPS-11βHSD1/KO plasma or exogenous GCs displayed reduced myonuclear accretion relative to WT counterparts. This study reveals that 11β-HSD1 inhibition aggravates muscle wasting in a model of AE-COPD, suggesting that therapeutic inhibition of 11β-HSD1 may not be appropriate to prevent muscle wasting in this setting.
- Open Access
Characterisation and Quenching Correction for an Al2O3:C Optical Fibre Real Time System in Therapeutic Proton, Helium, and Carbon-Charged Beams
Real time radioluminescence fibre-based detectors were investigated for application in proton, helium, and carbon therapy dosimetry. The Al2O3:C probes are made of one single crystal (1 mm) and two droplets of micro powder in two sizes (38 μm and 4 μm) mixed with a water-equivalent binder. The fibres were irradiated behind different thicknesses of solid slabs, and the Bragg curves presented a quenching effect attributed to the nonlinear response of the radioluminescence (RL) signal as a function of linear energy transfer (LET). Experimental data and Monte Carlo simulations were utilised to acquire a quenching correction method, adapted from Birks’ formulation, to restore the linear dose–response for particle therapy beams. The method for quenching correction was applied and yielded the best results for the ‘4 μm’ optical fibre probe, with an agreement at the Bragg peak of 1.4% (160 MeV), and 1.5% (230 MeV) for proton-charged particles; 2.4% (150 MeV/u) for helium-charged particles and of 4.8% (290 MeV/u) and 2.9% (400 MeV/u) for the carbon-charged particles. The most substantial deviations for the ‘4 μm’ optical fibre probe were found at the falloff regions, with ~3% (protons), ~5% (helium) and 6% (carbon).
Open AccessCharacterisation and Quenching Correction for an Al2O3:C Optical Fibre Real Time System in Therapeutic Proton, Helium, and Carbon-Charged Beams
Real time radioluminescence fibre-based detectors were investigated for application in proton, helium, and carbon therapy dosimetry. The Al2O3:C probes are made of one single crystal (1 mm) and two droplets of micro powder in two sizes (38 μm and 4 μm) mixed with a water-equivalent binder. The fibres were irradiated behind different thicknesses of solid slabs, and the Bragg curves presented a quenching effect attributed to the nonlinear response of the radioluminescence (RL) signal as a function of linear energy transfer (LET). Experimental data and Monte Carlo simulations were utilised to acquire a quenching correction method, adapted from Birks’ formulation, to restore the linear dose–response for particle therapy beams. The method for quenching correction was applied and yielded the best results for the ‘4 μm’ optical fibre probe, with an agreement at the Bragg peak of 1.4% (160 MeV), and 1.5% (230 MeV) for proton-charged particles; 2.4% (150 MeV/u) for helium-charged particles and of 4.8% (290 MeV/u) and 2.9% (400 MeV/u) for the carbon-charged particles. The most substantial deviations for the ‘4 μm’ optical fibre probe were found at the falloff regions, with ~3% (protons), ~5% (helium) and 6% (carbon).
- 27 May 2022
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 67 (11) , 115015
Deep learning for dose assessment in radiotherapy by the super-localization of vaporized nanodroplets in high frame rate ultrasound imaging
Objective. External beam radiotherapy is aimed to precisely deliver a high radiation dose to malignancies, while optimally sparing surrounding healthy tissues. With the advent of increasingly complex treatment plans, the delivery should preferably be verified by quality assurance methods. Recently, online ultrasound imaging of vaporized radiosensitive nanodroplets was proposed as a promising tool for in vivo dosimetry in radiotherapy. Previously, the detection of sparse vaporization events was achieved by applying differential ultrasound (US) imaging followed by intensity thresholding using subjective parameter tuning, which is sensitive to image artifacts. Approach . A generalized deep learning solution (i.e. BubbleNet) is proposed to localize vaporized nanodroplets on differential US frames, while overcoming the aforementioned limitation. A 5-fold cross-validation was performed on a diversely composed 5747-frame training/validation dataset by manual segmentation. BubbleNet was then applied on a test dataset of 1536 differential US frames to evaluate dosimetric features. The intra-observer variability was determined by scoring the Dice similarity coefficient (DSC) on 150 frames segmented twice. Additionally, the BubbleNet generalization capability was tested on an external test dataset of 432 frames acquired by a phased array transducer at a much lower ultrasound frequency and reconstructed with unconventional pixel dimensions with respect to the training dataset. Main results. The median DSC in the 5-fold cross validation was equal to ∼0.88, which was in line with the intra-observer variability (=0.86). Next, BubbleNet was employed to detect vaporizations in differential US frames obtained during the irradiation of phantoms with a 154 MeV proton beam or a 6 MV photon beam. BubbleNet improved the bubble-count statistics by ∼30% compared to the earlier established intensity-weighted thresholding. The proton range was verified with a −0.8 mm accuracy. Significance. BubbleNet is a flexible tool to localize individual vaporized nanodroplets on experimentally acquired US images, which improves the sensitivity compared to former thresholding-weighted methods.
- 27 May 2022
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 67 (11) , 115015
Deep learning for dose assessment in radiotherapy by the super-localization of vaporized nanodroplets in high frame rate ultrasound imaging
Objective. External beam radiotherapy is aimed to precisely deliver a high radiation dose to malignancies, while optimally sparing surrounding healthy tissues. With the advent of increasingly complex treatment plans, the delivery should preferably be verified by quality assurance methods. Recently, online ultrasound imaging of vaporized radiosensitive nanodroplets was proposed as a promising tool for in vivo dosimetry in radiotherapy. Previously, the detection of sparse vaporization events was achieved by applying differential ultrasound (US) imaging followed by intensity thresholding using subjective parameter tuning, which is sensitive to image artifacts. Approach . A generalized deep learning solution (i.e. BubbleNet) is proposed to localize vaporized nanodroplets on differential US frames, while overcoming the aforementioned limitation. A 5-fold cross-validation was performed on a diversely composed 5747-frame training/validation dataset by manual segmentation. BubbleNet was then applied on a test dataset of 1536 differential US frames to evaluate dosimetric features. The intra-observer variability was determined by scoring the Dice similarity coefficient (DSC) on 150 frames segmented twice. Additionally, the BubbleNet generalization capability was tested on an external test dataset of 432 frames acquired by a phased array transducer at a much lower ultrasound frequency and reconstructed with unconventional pixel dimensions with respect to the training dataset. Main results. The median DSC in the 5-fold cross validation was equal to ∼0.88, which was in line with the intra-observer variability (=0.86). Next, BubbleNet was employed to detect vaporizations in differential US frames obtained during the irradiation of phantoms with a 154 MeV proton beam or a 6 MV photon beam. BubbleNet improved the bubble-count statistics by ∼30% compared to the earlier established intensity-weighted thresholding. The proton range was verified with a −0.8 mm accuracy. Significance. BubbleNet is a flexible tool to localize individual vaporized nanodroplets on experimentally acquired US images, which improves the sensitivity compared to former thresholding-weighted methods.
- Open Access
- 11 February 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-8
Virtual monoenergetic micro-CT imaging in mice with artificial intelligence
Micro cone-beam computed tomography (µCBCT) imaging is of utmost importance for carrying out extensive preclinical research in rodents. The imaging of animals is an essential step prior to preclinical precision irradiation, but also in the longitudinal assessment of treatment outcomes. However, imaging artifacts such as beam hardening will occur due to the low energetic nature of the X-ray imaging beam (i.e., 60 kVp). Beam hardening artifacts are especially difficult to resolve in a ‘pancake’ imaging geometry with stationary source and detector, where the animal is rotated around its sagittal axis, and the X-ray imaging beam crosses a wide range of thicknesses. In this study, a seven-layer U-Net based network architecture (vMonoCT) is adopted to predict virtual monoenergetic X-ray projections from polyenergetic X-ray projections. A Monte Carlo simulation model is developed to compose a training dataset of 1890 projection pairs. Here, a series of digital anthropomorphic mouse phantoms was derived from the reference DigiMouse phantom as simulation geometry. vMonoCT was trained on 1512 projection pairs (= 80%) and tested on 378 projection pairs (= 20%). The percentage error calculated for the test dataset was 1.7 ± 0.4%. Additionally, the vMonoCT model was evaluated on a retrospective projection dataset of five mice and one frozen cadaver. It was found that beam hardening artifacts were minimized after image reconstruction of the vMonoCT-corrected projections, and that anatomically incorrect gradient errors were corrected in the cranium up to 15%. Our results disclose the potential of Artificial Intelligence to enhance the µCBCT image quality in biomedical applications. vMonoCT is expected to contribute to the reproducibility of quantitative preclinical applications such as precision irradiations in X-ray cabinets, and to the evaluation of longitudinal imaging data in extensive preclinical studies.
- 11 February 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-8
Open AccessVirtual monoenergetic micro-CT imaging in mice with artificial intelligence
Micro cone-beam computed tomography (µCBCT) imaging is of utmost importance for carrying out extensive preclinical research in rodents. The imaging of animals is an essential step prior to preclinical precision irradiation, but also in the longitudinal assessment of treatment outcomes. However, imaging artifacts such as beam hardening will occur due to the low energetic nature of the X-ray imaging beam (i.e., 60 kVp). Beam hardening artifacts are especially difficult to resolve in a ‘pancake’ imaging geometry with stationary source and detector, where the animal is rotated around its sagittal axis, and the X-ray imaging beam crosses a wide range of thicknesses. In this study, a seven-layer U-Net based network architecture (vMonoCT) is adopted to predict virtual monoenergetic X-ray projections from polyenergetic X-ray projections. A Monte Carlo simulation model is developed to compose a training dataset of 1890 projection pairs. Here, a series of digital anthropomorphic mouse phantoms was derived from the reference DigiMouse phantom as simulation geometry. vMonoCT was trained on 1512 projection pairs (= 80%) and tested on 378 projection pairs (= 20%). The percentage error calculated for the test dataset was 1.7 ± 0.4%. Additionally, the vMonoCT model was evaluated on a retrospective projection dataset of five mice and one frozen cadaver. It was found that beam hardening artifacts were minimized after image reconstruction of the vMonoCT-corrected projections, and that anatomically incorrect gradient errors were corrected in the cranium up to 15%. Our results disclose the potential of Artificial Intelligence to enhance the µCBCT image quality in biomedical applications. vMonoCT is expected to contribute to the reproducibility of quantitative preclinical applications such as precision irradiations in X-ray cabinets, and to the evaluation of longitudinal imaging data in extensive preclinical studies.
- Open Access
Deep Learning Based Automated Orthotopic Lung Tumor Segmentation in Whole-Body Mouse CT-Scans
Lung cancer is the leading cause of cancer related deaths worldwide. The development of orthotopic mouse models of lung cancer, which recapitulates the disease more realistically compared to the widely used subcutaneous tumor models, is expected to critically aid the development of novel therapies to battle lung cancer or related comorbidities such as cachexia. However, follow-up of tumor take, tumor growth and detection of therapeutic effects is difficult, time consuming and requires a vast number of animals in orthotopic models. Here, we describe a solution for the fully automatic segmentation and quantification of orthotopic lung tumor volume and mass in whole-body mouse computed tomography (CT) scans. The goal is to drastically enhance the efficiency of the research process by replacing time-consuming manual procedures with fast, automated ones. A deep learning algorithm was trained on 60 unique manually delineated lung tumors and evaluated by four-fold cross validation. Quantitative performance metrics demonstrated high accuracy and robustness of the deep learning algorithm for automated tumor volume analyses (mean dice similarity coefficient of 0.80), and superior processing time (69 times faster) compared to manual segmentation. Moreover, manual delineations of the tumor volume by three independent annotators was sensitive to bias in human interpretation while the algorithm was less vulnerable to bias. In addition, we showed that besides longitudinal quantification of tumor development, the deep learning algorithm can also be used in parallel with the previously published method for muscle mass quantification and to optimize the experimental design reducing the number of animals needed in preclinical studies. In conclusion, we implemented a method for fast and highly accurate tumor quantification with minimal operator involvement in data analysis. This deep learning algorithm provides a helpful tool for the noninvasive detection and analysis of tumor take, tumor growth and therapeutic effects in mouse orthotopic lung cancer models.
Open AccessDeep Learning Based Automated Orthotopic Lung Tumor Segmentation in Whole-Body Mouse CT-Scans
Lung cancer is the leading cause of cancer related deaths worldwide. The development of orthotopic mouse models of lung cancer, which recapitulates the disease more realistically compared to the widely used subcutaneous tumor models, is expected to critically aid the development of novel therapies to battle lung cancer or related comorbidities such as cachexia. However, follow-up of tumor take, tumor growth and detection of therapeutic effects is difficult, time consuming and requires a vast number of animals in orthotopic models. Here, we describe a solution for the fully automatic segmentation and quantification of orthotopic lung tumor volume and mass in whole-body mouse computed tomography (CT) scans. The goal is to drastically enhance the efficiency of the research process by replacing time-consuming manual procedures with fast, automated ones. A deep learning algorithm was trained on 60 unique manually delineated lung tumors and evaluated by four-fold cross validation. Quantitative performance metrics demonstrated high accuracy and robustness of the deep learning algorithm for automated tumor volume analyses (mean dice similarity coefficient of 0.80), and superior processing time (69 times faster) compared to manual segmentation. Moreover, manual delineations of the tumor volume by three independent annotators was sensitive to bias in human interpretation while the algorithm was less vulnerable to bias. In addition, we showed that besides longitudinal quantification of tumor development, the deep learning algorithm can also be used in parallel with the previously published method for muscle mass quantification and to optimize the experimental design reducing the number of animals needed in preclinical studies. In conclusion, we implemented a method for fast and highly accurate tumor quantification with minimal operator involvement in data analysis. This deep learning algorithm provides a helpful tool for the noninvasive detection and analysis of tumor take, tumor growth and therapeutic effects in mouse orthotopic lung cancer models.
- 4 May 2021
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 66 (10) , 105001
Artificial intelligence supported single detector multi-energy proton radiography system
Proton radiography imaging was proposed as a promising technique to evaluate internal anatomical changes, to enable pre-treatment patient alignment, and most importantly, to optimize the patient specific CT number to stopping-power ratio conversion. The clinical implementation rate of proton radiography systems is still limited due to their complex bulky design, together with the persistent problem of (in)elastic nuclear interactions and multiple Coulomb scattering (i.e. range mixing). In this work, a compact multi-energy proton radiography system was proposed in combination with an artificial intelligence network architecture (ProtonDSE) to remove the persistent problem of proton scatter in proton radiography. A realistic Monte Carlo model of the Proteus ® One accelerator was built at 200 and 220 MeV to isolate the scattered proton signal in 236 proton radiographies of 80 digital anthropomorphic phantoms. ProtonDSE was trained to predict the proton scatter distribution at two beam energies in a 60%/25%/15% scheme for training, testing, and validation. A calibration procedure was proposed to derive the water equivalent thickness image based on the detector dose response relationship at both beam energies. ProtonDSE network performance was evaluated with quantitative metrics that showed an overall mean absolute percentage error below 1.4% ± 0.4% in our test dataset. For one example patient, detector dose to WET conversions were performed based on the total dose ( I Total ), the primary proton dose ( I Primary ), and the ProtonDSE corrected detector dose ( I Corrected ). The determined WET accuracy was compared with respect to the reference WET by idealistic raytracing in a manually delineated region-of-interest inside the brain. The error was determined 4.3% ± 4.1% for WET ( I Total ) , 2.2% ± 1.4% for WET ( I Primary ) , and 2.5% ± 2.0% for WET ( I Corrected ) .
- 4 May 2021
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 66 (10) , 105001
Artificial intelligence supported single detector multi-energy proton radiography system
Proton radiography imaging was proposed as a promising technique to evaluate internal anatomical changes, to enable pre-treatment patient alignment, and most importantly, to optimize the patient specific CT number to stopping-power ratio conversion. The clinical implementation rate of proton radiography systems is still limited due to their complex bulky design, together with the persistent problem of (in)elastic nuclear interactions and multiple Coulomb scattering (i.e. range mixing). In this work, a compact multi-energy proton radiography system was proposed in combination with an artificial intelligence network architecture (ProtonDSE) to remove the persistent problem of proton scatter in proton radiography. A realistic Monte Carlo model of the Proteus ® One accelerator was built at 200 and 220 MeV to isolate the scattered proton signal in 236 proton radiographies of 80 digital anthropomorphic phantoms. ProtonDSE was trained to predict the proton scatter distribution at two beam energies in a 60%/25%/15% scheme for training, testing, and validation. A calibration procedure was proposed to derive the water equivalent thickness image based on the detector dose response relationship at both beam energies. ProtonDSE network performance was evaluated with quantitative metrics that showed an overall mean absolute percentage error below 1.4% ± 0.4% in our test dataset. For one example patient, detector dose to WET conversions were performed based on the total dose ( I Total ), the primary proton dose ( I Primary ), and the ProtonDSE corrected detector dose ( I Corrected ). The determined WET accuracy was compared with respect to the reference WET by idealistic raytracing in a manually delineated region-of-interest inside the brain. The error was determined 4.3% ± 4.1% for WET ( I Total ) , 2.2% ± 1.4% for WET ( I Primary ) , and 2.5% ± 2.0% for WET ( I Corrected ) .
- Open Access
- 18 March 2021
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 94 (1120) , 20201384
The potential application of dual-energy subtraction radiography for COVID-19 pneumonia imaging
X-ray imaging plays a crucial role in the confirmation of COVID-19 pneumonia. Chest X-ray radiography and CT are two major imaging techniques that are currently adopted in the diagnosis of COVID-19 pneumonia. However, dual-energy subtraction radiography is hardly discussed as potential COVID-19 imaging application. More advanced X-ray radiography equipment often supports dual-energy subtraction X-ray radiography. Dual-energy subtraction radiography enables the calculation of pseudo-radiographs, in which bones are removed and only soft-tissues are highlighted. In this commentary, the author would like to draw the attention to the potential use of dual-energy subtraction X-ray radiography (i.e. soft-tissue pseudo-radiography) for the assessment and the longitudinal follow-up of COVID-19 pneumonia.
- 18 March 2021
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 94 (1120) , 20201384
Open AccessThe potential application of dual-energy subtraction radiography for COVID-19 pneumonia imaging
X-ray imaging plays a crucial role in the confirmation of COVID-19 pneumonia. Chest X-ray radiography and CT are two major imaging techniques that are currently adopted in the diagnosis of COVID-19 pneumonia. However, dual-energy subtraction radiography is hardly discussed as potential COVID-19 imaging application. More advanced X-ray radiography equipment often supports dual-energy subtraction X-ray radiography. Dual-energy subtraction radiography enables the calculation of pseudo-radiographs, in which bones are removed and only soft-tissues are highlighted. In this commentary, the author would like to draw the attention to the potential use of dual-energy subtraction X-ray radiography (i.e. soft-tissue pseudo-radiography) for the assessment and the longitudinal follow-up of COVID-19 pneumonia.
- 8 July 2020
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 65 (14) , 145002
A Monte Carlo based scatter removal method for non-isocentric cone-beam CT acquisitions using a deep convolutional autoencoder
The primary cone-beam computed tomography (CBCT) imaging beam scatters inside the patient and produces a contaminating photon fluence that is registered by the detector. Scattered photons cause artifacts in the image reconstruction, and are partially responsible for the inferior image quality compared to diagnostic fan-beam CT. In this work, a deep convolutional autoencoder (DCAE) and projection-based scatter removal algorithm were constructed for the ImagingRing TM system on rails (IRr), which allows for non-isocentric acquisitions around virtual rotation centers with its independently rotatable source and detector arms. A Monte Carlo model was developed to simulate ( i ) a non-isocentric training dataset of ≈1200 projection pairs (primary + scatter) from 27 digital head-and-neck cancer patients around five different virtual rotation centers (DCAE NONISO ), and ( ii ) an isocentric dataset existing of ≈1200 projection pairs around the physical rotation center (DCAE ISO ). The scatter removal performance of both DCAE networks was investigated in two digital anthropomorphic phantom simulations and due to superior performance only the DCAE NONISO was applied on eight real patient acquisitions. Measures for the quantitative error, the signal-to-noise ratio, and the similarity were evaluated for two simulated digital head-and-neck patients, and the contrast-to-noise ratio (CNR) was investigated between muscle and adipose tissue in the real patient image reconstructions. Image quality metrics were compared between the uncorrected data, the currently implemented heuristic scatter correction data, and the DCAE corrected image reconstruction. The DCAE NONISO corrected image reconstructions of two digital patient simulations showed superior image quality metrics compared to the uncorrected and corrected image reconstructions using a heuristic scatter removal. The proposed DCAE NONISO scatter correction in this study was successfully demonstrated in real non-isocentric patient CBCT acquisitions and achieved statistically significant higher CNRs compared to the uncorrected or the heuristic corrected image data. This paper presents for the first time a projection-based scatter removal algorithm for isocentric and non-isocentric CBCT imaging using a deep convolutional autoencoder trained on Monte Carlo composed datasets. The algorithm was successfully applied to real patient data.
- 8 July 2020
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 65 (14) , 145002
A Monte Carlo based scatter removal method for non-isocentric cone-beam CT acquisitions using a deep convolutional autoencoder
The primary cone-beam computed tomography (CBCT) imaging beam scatters inside the patient and produces a contaminating photon fluence that is registered by the detector. Scattered photons cause artifacts in the image reconstruction, and are partially responsible for the inferior image quality compared to diagnostic fan-beam CT. In this work, a deep convolutional autoencoder (DCAE) and projection-based scatter removal algorithm were constructed for the ImagingRing TM system on rails (IRr), which allows for non-isocentric acquisitions around virtual rotation centers with its independently rotatable source and detector arms. A Monte Carlo model was developed to simulate ( i ) a non-isocentric training dataset of ≈1200 projection pairs (primary + scatter) from 27 digital head-and-neck cancer patients around five different virtual rotation centers (DCAE NONISO ), and ( ii ) an isocentric dataset existing of ≈1200 projection pairs around the physical rotation center (DCAE ISO ). The scatter removal performance of both DCAE networks was investigated in two digital anthropomorphic phantom simulations and due to superior performance only the DCAE NONISO was applied on eight real patient acquisitions. Measures for the quantitative error, the signal-to-noise ratio, and the similarity were evaluated for two simulated digital head-and-neck patients, and the contrast-to-noise ratio (CNR) was investigated between muscle and adipose tissue in the real patient image reconstructions. Image quality metrics were compared between the uncorrected data, the currently implemented heuristic scatter correction data, and the DCAE corrected image reconstruction. The DCAE NONISO corrected image reconstructions of two digital patient simulations showed superior image quality metrics compared to the uncorrected and corrected image reconstructions using a heuristic scatter removal. The proposed DCAE NONISO scatter correction in this study was successfully demonstrated in real non-isocentric patient CBCT acquisitions and achieved statistically significant higher CNRs compared to the uncorrected or the heuristic corrected image data. This paper presents for the first time a projection-based scatter removal algorithm for isocentric and non-isocentric CBCT imaging using a deep convolutional autoencoder trained on Monte Carlo composed datasets. The algorithm was successfully applied to real patient data.
- Top Cited PapersOpen Access
- 1 January 2020
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 13, 1-6
Evaluation of measures for assessing time-saving of automatic organ-at-risk segmentation in radiotherapy
- 1 January 2020
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 13, 1-6
Top Cited PapersOpen AccessEvaluation of measures for assessing time-saving of automatic organ-at-risk segmentation in radiotherapy